Calcipotriol plus Betamethasone Dipropionate Scalp Formulation Is Effective and Well Tolerated in the Treatment of Scalp Psoriasis: A Phase II Study
Authors:
- Colin BuckleyCBColin Buckley
- Vibeke HoffmannVHVibeke Hoffmann
- Jerry ShapiroJSJerry Shapiro
- Seppo SaariSSSeppo Saari
- Frederic CambazardFCFrederic Cambazard
- Mette MilsgaardMMMette Milsgaard
- 8 May 2008
- journal article
- research article
- Published by S. Karger AG in Dermatology
- Vol. 217 (2) , 107-113
Abstract
Background: There is a need for more effective therapy for scalp psoriasis. Objective: To assess the efficacy and safety of a 2-compound scalp formulation including calcipotriol and betamethasone dipropionate in the treatment of scalp psoriasis. Methods: Patients (n = 218) with scalp psoriasis were randomized to treatment with the 2-compound scalp formulation (n = 108) or betamethasone dipropionate in the same vehicle (n = 110). The treatments were applied once daily on the scalp for up to 8 weeks. Results: The 2-compound scalp formulation showed a significantly higher efficacy than betamethasone dipropionate on the total sign score at the end of treatment (p = 0.042) and after 2 weeks (p = 0.005). Conclusion: The calcipotriol plus betamethasone dipropionate scalp formulation was superior to betamethasone dipropionate in the same vehicle when used once daily for up to 8 weeks in the treatment of scalp psoriasis.Keywords
This publication has 22 references indexed in Scilit:
- Cost-Effectiveness Model of Topical Treatment of Mild to Moderate Psoriasis Vulgaris in GermanyDermatology, 2007
- Cost-Effectiveness of Once-Daily Treatment with Calcipotriol/Betamethasone Dipropionate Followed by Calcipotriol Alone Compared with Tacalcitol in the Treatment of Psoriasis vulgarisDermatology, 2005
- A Two-Compound Product Containing Calcipotriol and Betamethasone Dipropionate Provides Rapid, Effective Treatment of Psoriasis vulgaris regardless of Baseline Disease SeverityDermatology, 2005
- Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgarisBritish Journal of Dermatology, 2004
- Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trialBritish Journal of Dermatology, 2002
- Efficacy and safety of twice-daily augmented betamethasone dipropionate lotion versus clobetasol propionate solution in patients with moderate-to-severe scalp psoriasisClinical Therapeutics, 1995
- A comparative study of calcipotriol ointment and tar in chronic plaque psoriasisBritish Journal of Dermatology, 1994
- A multicentre, parallel-group comparison of calcipotriol ointment and short-contact dithranol therapy in chronic plaque psoriasisBritish Journal of Dermatology, 1992
- Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgarisJournal of the American Academy of Dermatology, 1992
- Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgarisThe Lancet, 1991